Federal Charges Filed in Counterfeit Ozempic Scheme in Florida
A scheme to sell counterfeit Ozempic in Florida has been uncovered, leading to federal charges against two Indian citizens, Vicky Ramancha and Swapnadip Roy, who were living in the United Arab Emirates. The charges include smuggling, selling counterfeit drugs, and conspiracy to defraud the United States. According to federal prosecutors in the Middle District of Florida, the defendants are accused of moving counterfeit Ozempic from illegitimate suppliers in China into the U.S. between 2023 and 2024. They allegedly stored thousands of counterfeit units in warehouses across the country before distributing them at heavily discounted prices to Florida businesses, including a company located in Lakeland. Investigators noted that the counterfeit drugs featured fraudulent or missing serial numbers and included fake packaging, labeling, and needles designed to mimic authentic Ozempic. The seriousness of the situation is underscored by medical experts who warn about the health risks associated with counterfeit medications. Dr. Steven Goldberg, Chief Medical Officer at HealthTrack, emphasized that counterfeit drugs can contain harmful substances or lack the active ingredients necessary for treatment. He advised that consumers should verify the prescriber's name and the pharmacy's authenticity, suggesting that they check the Florida Pharmacy Board website for confirmation. Roy has been extradited from Italy to the U.S. and has appeared in a Tampa federal court. If convicted, both defendants could face decades in federal prison. The case highlights the ongoing issue of counterfeit medications and the risks they pose to public health, as well as the importance of ensuring that prescriptions are obtained from legitimate sources.




